1 |
CCR5
| 5件: Viral life cycle - HIV-1 Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Viral protein interaction with cytokine and cytokine receptor, Toxoplasmosis, Viral carcinogenesis | D06670
D06670
|
Maraviroc
| 2件: 46 46, 84 |
2 |
CCR5
| 5件: Viral life cycle - HIV-1 Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Viral protein interaction with cytokine and cytokine receptor, Toxoplasmosis, Viral carcinogenesis | D09878
D09878
|
Cenicriviroc
| 1件: 94 94 |
3 |
MAPK14
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
4 |
MAPK14
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
5 |
ALOX5
| 1件: Toxoplasmosis Toxoplasmosis | D00414
D00414
|
Zileuton
| 3件: 85 85, 160, 164 |
6 |
ALOX5
| 1件: Toxoplasmosis Toxoplasmosis | D01773
D01773
|
Oxatomide
| 1件: 113 113 |
7 |
IFNG
| 3件: Type I diabetes mellitus Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D04242
D04242
|
Fontolizumab
| 1件: 46 46 |
8 |
IFNG
| 3件: Type I diabetes mellitus Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D11120
D11120
|
Emapalumab
| 3件: 49 49, 65, 107 |
9 |
IFNGR1
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D00747
D00747
|
Interferon gamma-1b
| 7件: 18 18, 65, 85, 228, 299, 301, 326 |
10 |
IFNGR2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D00747
D00747
|
Interferon gamma-1b
| 7件: 18 18, 65, 85, 228, 299, 301, 326 |
11 |
IL10
| 4件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, Toxoplasmosis, Tuberculosis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
12 |
IL12A
| 3件: Type I diabetes mellitus Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D09214
D09214
|
Ustekinumab
| 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 |
13 |
IL12B
| 3件: Type I diabetes mellitus Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D09214
D09214
|
Ustekinumab
| 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 |
14 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D09959
D09959
|
Ruxolitinib
| 3件: 60 60, 65, 228 |
15 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D09970
D09970
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
16 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10308
D10308
|
Baricitinib
| 13件: 2 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 |
17 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10653
D10653
|
Peficitinib
| 1件: 46 46 |
18 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10871
D10871
|
Filgotinib
| 6件: 46 46, 53, 96, 97, 222, 271 |
19 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10944
D10944
|
Itacitinib
| 4件: 46 46, 51, 97, 228 |
20 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10994
D10994
|
Upadacitinib
| 8件: 40 40, 41, 46, 49, 96, 97, 107, 271 |
21 |
JAK1
| 3件: Toxoplasmosis Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D11400
D11400
|
Abrocitinib
| 1件: 84 84 |
22 |
JAK2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D09959
D09959
|
Ruxolitinib
| 3件: 60 60, 65, 228 |
23 |
JAK2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D09970
D09970
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
24 |
JAK2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D10308
D10308
|
Baricitinib
| 13件: 2 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 |
25 |
JAK2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D10653
D10653
|
Peficitinib
| 1件: 46 46 |
26 |
NFKB1
| 5件: Yersinia infection Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis | D01146
D01146
|
Iguratimod
| 5件: 46 46, 51, 53, 271, 300 |
27 |
MAPK11
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
28 |
MAPK11
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
29 |
MAPK13
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
30 |
MAPK13
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
31 |
BCL2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D10679
D10679
|
Venetoclax
| 1件: 28 28 |
32 |
RELA
| 5件: Yersinia infection Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis | D12181
D12181
|
Edasalonexent
| 1件: 113 113 |
33 |
MAPK12
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
34 |
MAPK12
| 4件: VEGF signaling pathway VEGF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
35 |
TGFB1
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
36 |
TGFB2
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
37 |
TGFB3
| 2件: Toxoplasmosis Toxoplasmosis, Tuberculosis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
38 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00742
D00742
|
Etanercept
| 16件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
39 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00754
D00754
|
Thalidomide
| 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
40 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
41 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02597
D02597
|
Adalimumab
| 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
42 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02598
D02598
|
Infliximab
| 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
43 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D03441
D03441
|
Certolizumab pegol
| 8件: 37 37, 46, 49, 96, 97, 107, 226, 271 |
44 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04358
D04358
|
Golimumab
| 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 |
45 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04687
D04687
|
Lenalidomide
| 8件: 16 16, 26, 28, 34, 49, 284, 300, 331 |
46 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D05393
D05393
|
Pegsunercept
| 1件: 46 46 |
47 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
48 |
TNF
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D09944
D09944
|
Ozoralizumab
| 1件: 46 46 |
49 |
TYK2
| 1件: Toxoplasmosis Toxoplasmosis | D09970
D09970
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
50 |
TYK2
| 1件: Toxoplasmosis Toxoplasmosis | D11817
D11817
|
Deucravacitinib
| 3件: 49 49, 96, 97 |
51 |
CASP9
| 4件: VEGF signaling pathway VEGF signaling pathway, Toxoplasmosis, Tuberculosis, Viral myocarditis | D11195
D11195
|
Rimiducid
| 6件: 19 19, 60, 65, 284, 285, 326 |
52 |
CD40
| 3件: Toxoplasmosis Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis | D11357
D11357
|
Bleselumab
| 1件: 222 222 |
53 |
CD40
| 3件: Toxoplasmosis Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis | D11597
D11597
|
Ravagalimab
| 2件: 53 53, 97 |
54 |
CD40
| 3件: Toxoplasmosis Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis | D11610
D11610
|
Iscalimab
| 2件: 49 49, 53 |
55 |
CD40LG
| 2件: Toxoplasmosis Toxoplasmosis, Viral myocarditis | D06193
D06193
|
Toralizumab
| 1件: 63 63 |